<\/p>\n
NovoRapid FlexPen<\/strong> is a pre-filled disposable insulin pen containing insulin aspart<\/strong> (100 units\/mL, 3 mL pen) — a rapid-acting insulin analogue<\/strong> used at meal-times (bolus insulin) in type 1 and type 2 diabetes. It has an onset of 10–15 minutes, peak effect at 1–3 hours, and total duration of 3–5 hours. Inject subcutaneously into the abdomen, thigh, or upper arm 5–15 minutes before a meal (or immediately after for unpredictable eaters). Usual dose: 0.5–1 unit per 10 g of carbohydrate, individualised to glucose, carb intake, and insulin sensitivity. Main risk: hypoglycaemia.<\/strong> Pair with a basal (long-acting) insulin in type 1 diabetes, or use alongside oral agents or basal insulin in type 2. Store unopened pens at 2–8°C; once in use, keep at room temperature < 30°C for up to 28 days.<\/p>\n<\/div>\n \ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n NovoRapid FlexPen is a pre-filled disposable pen containing 3 mL (300 units) of insulin aspart, dialing 1–60 units per dose in 1-unit increments. It contains insulin aspart (100 units\/mL, 3 mL pen) manufactured by Novo Nordisk, supplied in packs of 1 or 5 pre-filled pens.<\/p>\n insulin aspart is a rapid-acting insulin analogue<\/strong> — a meal-time (“bolus”) insulin used to match the post-meal glucose rise. NovoRapid (NovoLog in the US) is the originator brand worldwide.<\/p>\n Insulin is the natural hormone the pancreas releases after meals to help cells absorb glucose. In diabetes, this insulin response is either absent (type 1) or insufficient (type 2). Meal-time insulin injections replace that response.<\/p>\n Insulin aspart is made by substituting a proline with aspartic acid at position B28 of human insulin, which prevents the insulin molecules from clumping into hexamers — so they dissociate and absorb faster than regular human insulin. This gives a pharmacokinetic profile tailored to the meal-time glucose rise:<\/p>\n This profile closely mimics physiological post-meal insulin release — much better than regular human insulin, which has a slow 30-minute onset and a long 6–8 hour tail that can cause late hypoglycaemia.<\/p>\n Na\u010dasov\u00e1n\u00ed:<\/strong> inject 5–15 minutes before each meal. If meal timing is unpredictable (young children, unwell adults), injecting just before or even immediately after the meal is acceptable — this flexibility is a key advantage of rapid-acting analogues over regular insulin.<\/p>\n D\u00e1vkov\u00e1n\u00ed:<\/strong> individualised to the patient. Common starting approaches:<\/p>\n Injection technique:<\/strong><\/p>\n Most important:<\/strong><\/p>\n Lok\u00e1ln\u00ed:<\/strong><\/p>\n M\u00e9n\u011b \u010dast\u00e9, ale d\u016fle\u017eit\u00e9:<\/strong><\/p>\n Zvy\u0161uj\u00ed riziko hypoglyk\u00e9mie:<\/strong> sulfonylureas, meglitinides, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, propoxyphene, salicylates, sulfonamide antibiotics, somatostatin analogues, alcohol.<\/p>\n Reduce insulin effect:<\/strong> corticosteroids, oral contraceptives, thiazides, thyroid hormones, sympathomimetics, atypical antipsychotics, isoniazid, niacin, danazol, protease inhibitors.<\/p>\n Variable:<\/strong> beta-blockers (mask hypoglycaemia symptoms), lithium, octreotide.<\/p>\n In pregnancy:<\/strong> rapid-acting analogues are considered compatible and widely used. Discuss with your obstetric diabetes team.<\/p>\n Paediatric use:<\/strong> both NovoRapid and Apidra are approved for use in children (Apidra from 4 years, NovoRapid from 1 year) with appropriate paediatric dosing.<\/p>\n Yes. NovoRapid (used in most of the world) and NovoLog (used in the US and Canada) are the same drug — insulin aspart 100 units\/mL — made by Novo Nordisk. The different trade names are regional marketing, not different formulations.<\/p>\n 5–15 minutes before the meal is standard and gives the best glucose control. Injecting just before or immediately after is acceptable when meal timing is unpredictable — for young children, people with gastroparesis, or when you do not yet know how much you will eat. Injecting much later than that reduces control of the post-meal spike.<\/p>\n Eat a fast-acting carbohydrate immediately (15 g of glucose), then a slower-acting snack (bread, biscuits, sandwich) to cover the ongoing insulin action over the next 3–5 hours. Check glucose every 15–30 minutes. Severe or unresponsive hypoglycaemia needs glucagon or medical help.<\/p>\n In type 1 diabetes — yes, always. Rapid-acting insulin alone cannot provide 24-hour basal coverage, and stopping long-acting insulin in type 1 diabetes causes diabetic ketoacidosis within hours. In type 2 diabetes, NovoRapid FlexPen is often used alongside basal insulin (glargine, degludec) and oral agents.<\/p>\n No — rapid-acting analogues should not be mixed with long-acting analogues (glargine, degludec, detemir) in the same syringe. Use separate injections. You can give them at the same time with different pens.<\/p>\n Yes — rapid-acting analogues including aspart and glulisine are the standard insulins for continuous subcutaneous insulin infusion (CSII) pumps. Ask your diabetes team for pump-specific guidance.<\/p>\n Yes — once you take the first injection, the pen lasts 28 days at room temperature (below 30°C). Discard on day 29 even if insulin remains. Note the start date on the pen.<\/p>\n You can order NovoRapid FlexPen (100 units\/mL, 3 mL pen) from MedsBase in packs of 1 or 5 pre-filled pens. Insulin ships with temperature-protected packaging; worldwide shipping. Discreet packaging and genuine Novo Nordisk manufacturer stock.<\/p>\n <\/p>\n Dal\u0161\u00ed produkty v Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n \u2705 Fast glucose control Novorapid Flexpen contains insulin.<\/p>","protected":false},"featured_media":57688,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[4343,4348],"class_list":{"0":"post-57687","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-insulin","11":"product_tag-novorapid-flexpen","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/57687","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=57687"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/57688"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=57687"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=57687"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=57687"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=57687"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n
What Is NovoRapid FlexPen?<\/h2>\n
How Does NovoRapid FlexPen Work?<\/h2>\n
\n
D\u00e1vkov\u00e1n\u00ed a pod\u00e1n\u00ed<\/h2>\n
\n
\n
Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n
\n
\n
\n
Interakce s l\u00e9\u010divy<\/h2>\n
Who Should Not Use NovoRapid FlexPen?<\/h2>\n
\n
Storage and Handling<\/h2>\n
\n
\u010casto kladen\u00e9 dotazy<\/h2>\n
Is NovoRapid the same as insulin aspart or NovoLog?<\/h3>\n
When should I inject NovoRapid FlexPen — before or after the meal?<\/h3>\n
What if I accidentally inject too much?<\/h3>\n
Do I need basal (long-acting) insulin too?<\/h3>\n
Can I mix NovoRapid FlexPen with long-acting insulin in the same syringe?<\/h3>\n
Can NovoRapid FlexPen be used in insulin pumps?<\/h3>\n
Does NovoRapid FlexPen expire once the pen is in use?<\/h3>\n
Where can I buy NovoRapid FlexPen online?<\/h3>\n
Souvisej\u00edc\u00ed l\u00e9ky na diabetes<\/h2>\n
\n
Souvisej\u00edc\u00ed alternativy<\/h3>\n
\n
\n\u2705 Convenient pen design
\n\u2705 Adjustable dosing
\n\u2705 Reduced hypoglycemia risk
\n\u2705 Simple self-administration<\/p>\n